Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.
暂无分享,去创建一个
S. Kourembanas | S. A. Mitsialis | Sally H Vitali | R. Khalil | H. Christou | Marlin Touma | O. Reslan | Virak Mam | Alain F Tanbe | E. Arons | Elena Arons | S. Mitsialis | Alain F. Tanbe | Sally H. Vitali
[1] J. Westwick,et al. A novel murine model of severe pulmonary arterial hypertension. , 2011, American journal of respiratory and critical care medicine.
[2] P. Aaronson,et al. Key role of the RhoA/Rho kinase system in pulmonary hypertension. , 2011, Pulmonary pharmacology & therapeutics.
[3] H. Christou,et al. Heme Oxygenase-1 Does Not Mediate the Effects of Extracellular Acidosis on Vascular Smooth Muscle Cell Proliferation, Migration, and Susceptibility to Apoptosis , 2011, Journal of Vascular Research.
[4] C. Wagner,et al. Induction of Metabolic Acidosis with Ammonium Chloride (NH4Cl) in Mice and Rats – Species Differences and Technical Considerations , 2011, Cellular Physiology and Biochemistry.
[5] P. McNamara,et al. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension. , 2010, American journal of physiology. Heart and circulatory physiology.
[6] R. Khalil,et al. Sex hormones and vascular protection in pulmonary arterial hypertension. , 2010, Journal of cardiovascular pharmacology.
[7] M. Humbert,et al. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension. , 2010, European heart journal.
[8] Horst Olschewski,et al. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. , 2010, Journal of the American College of Cardiology.
[9] N. Voelkel,et al. Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension , 2010, Circulation.
[10] G. Raskob,et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. , 2010, Chest.
[11] Sally H Vitali,et al. Impaired Vasoconstriction and Nitric Oxide-Mediated Relaxation in Pulmonary Arteries of Hypoxia- and Monocrotaline-Induced Pulmonary Hypertensive Rats , 2010, Journal of Pharmacology and Experimental Therapeutics.
[12] M. Frid,et al. Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[13] Kurt R Stenmark,et al. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[14] Chengqun Huang,et al. NOTCH3 SIGNALING IS REQUIRED FOR THE DEVELOPMENT OF PULMONARY ARTERIAL HYPERTENSION , 2009, Nature Medicine.
[15] F. McGowan,et al. Divergent Cardiopulmonary Actions of Heme Oxygenase Enzymatic Products in Chronic Hypoxia , 2009, PloS one.
[16] A. Pries,et al. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease* , 2009, Critical care medicine.
[17] J. Stehlik,et al. Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure. , 2009, Journal of cardiac failure.
[18] E. Mark,et al. Interleukin-6 Overexpression Induces Pulmonary Hypertension , 2009, Circulation research.
[19] C. Burger. Pulmonary Hypertension in COPD: A Review and Consideration of the Role of Arterial Vasodilators , 2009, COPD.
[20] T. Murata,et al. Time-dependent phenotypic and contractile changes of pulmonary artery in chronic hypoxia-induced pulmonary hypertension. , 2009, Journal of pharmacological sciences.
[21] J. Guan,et al. The p38 mitogen‐activated protein kinase pathway is involved in the regulation of heme oxygenase‐1 by acidic extracellular pH in aortic smooth muscle cells , 2008, Journal of cellular biochemistry.
[22] C. Knoderer,et al. Use of Sildenafil to Facilitate Weaning From Inhaled Nitric Oxide in Children With Pulmonary Hypertension Following Surgery for Congenital Heart Disease , 2008, Journal of intensive care medicine.
[23] H. Farber. The Status of Pulmonary Arterial Hypertension in 2008 , 2008, Circulation.
[24] V. Kurup,et al. Pulmonary arterial remodeling induced by a Th2 immune response , 2008, The Journal of experimental medicine.
[25] N. Ambartsumian,et al. Reactivation of gammaHV68 induces neointimal lesions in pulmonary arteries of S100A4/Mts1-overexpressing mice in association with degradation of elastin. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[26] Manching Ku,et al. Control of Phenotypic Plasticity of Smooth Muscle Cells by Bone Morphogenetic Protein Signaling through the Myocardin-related Transcription Factors* , 2007, Journal of Biological Chemistry.
[27] M. Oka,et al. Endothelin-1 and Serotonin are Involved in Activation of RhoA/Rho Kinase Signaling in the Chronically Hypoxic Hypertensive Rat Pulmonary Circulation , 2007, Journal of cardiovascular pharmacology.
[28] U. Ikeda,et al. Interleukin-10 Expression Mediated by an Adeno-Associated Virus Vector Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats , 2007, Circulation research.
[29] U. Christians,et al. Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[30] Christine M. Miller,et al. Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[31] I. McMurtry,et al. Rodent models of PAH: are we there yet? , 2007, American journal of physiology. Lung cellular and molecular physiology.
[32] C. Rohlicek,et al. Decreased left ventricular function, myocarditis, and coronary arteriolar medial thickening following monocrotaline administration in adult rats. , 2007, Journal of applied physiology.
[33] N. Voelkel,et al. Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling. , 2007, American journal of respiratory and critical care medicine.
[34] Y. Shang,et al. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. , 2007, Journal of the American College of Cardiology.
[35] K. Stenmark,et al. Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[36] N. Voelkel,et al. Rho Kinase-Mediated Vasoconstriction Is Important in Severe Occlusive Pulmonary Arterial Hypertension in Rats , 2007, Circulation research.
[37] S. N. Murthy,et al. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction. , 2007, American journal of physiology. Heart and circulatory physiology.
[38] P. McNamara,et al. Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[39] R. Jones,et al. The influence of sex hormones on pulmonary vascular reactivity: possible vasodilator therapies for the treatment of pulmonary hypertension. , 2006, Current vascular pharmacology.
[40] P. Pacaud,et al. Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension , 2005, British journal of pharmacology.
[41] T. Welte,et al. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension , 2005, European Respiratory Journal.
[42] W. Seeger,et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. , 2005, The Journal of clinical investigation.
[43] Marguerite Hatch,et al. Ethylene glycol induces hyperoxaluria without metabolic acidosis in rats. , 2005, American journal of physiology. Renal physiology.
[44] M. Humbert,et al. Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension , 2005, Circulation.
[45] D. Ivy,et al. Development of Occlusive Neointimal Lesions in Distal Pulmonary Arteries of Endothelin B Receptor—Deficient Rats: A New Model of Severe Pulmonary Arterial Hypertension , 2005, Circulation.
[46] S. Kourembanas,et al. Extracellular acidosis induces heme oxygenase-1 expression in vascular smooth muscle cells. , 2005, American journal of physiology. Heart and circulatory physiology.
[47] S. Archer,et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. , 2005, The Journal of clinical investigation.
[48] J. Loscalzo,et al. Pulmonary arterial hypertension , 2006, The New England journal of medicine.
[49] K. Morris,et al. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[50] R. Budhiraja,et al. Endothelial Dysfunction in Pulmonary Hypertension , 2004, Circulation.
[51] H. Farber,et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.
[52] N. Ambartsumian,et al. S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy. , 2004, The American journal of pathology.
[53] W. Seeger,et al. Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. , 2004, American journal of respiratory and critical care medicine.
[54] P. D. del Nido,et al. Hypoxia and Stretch Regulate Intercellular Communication in Vascular Smooth Muscle Cells Through Reactive Oxygen Species Formation , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[55] G. Berry,et al. Simvastatin Rescues Rats From Fatal Pulmonary Hypertension by Inducing Apoptosis of Neointimal Smooth Muscle Cells , 2003, Circulation.
[56] E. Chang,et al. Metabolic acidosis in rats increases intestinal NHE2 and NHE3 expression and function. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[57] M. Yanagisawa,et al. Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[58] S. Narumiya,et al. Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling. , 2001, American journal of respiratory and critical care medicine.
[59] M. Yanagisawa,et al. Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[60] P. Hirth,et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[61] R. Nagai,et al. Vascular smooth muscle cell phenotypes in primary pulmonary hypertension. , 2001, The European respiratory journal.
[62] R. Rabkin,et al. Effect of metabolic acidosis on the insulin-like growth factor-I system and cathepsins B and L gene expression in the kidney. , 2000, The Journal of laboratory and clinical medicine.
[63] C. Kleeman,et al. Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease. , 2000, Kidney international.
[64] P. McLoughlin,et al. Chronic hypercapnia inhibits hypoxic pulmonary vascular remodeling. , 2000, American journal of physiology. Heart and circulatory physiology.
[65] L. Shimoda,et al. Altered pulmonary vasoreactivity in the chronically hypoxic lung. , 2000, Physiological research.
[66] H. Itoh,et al. Effects of the endothelin ET(A) receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats. , 1999, European journal of pharmacology.
[67] N. Voelkel,et al. Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. , 1999, The Journal of clinical investigation.
[68] R Busse,et al. NO: the primary EDRF. , 1999, Journal of molecular and cellular cardiology.
[69] B. Thompson,et al. Amiloride analogs inhibit chronic hypoxic pulmonary hypertension. , 1998, American journal of respiratory and critical care medicine.
[70] Wei Zhang,et al. Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. , 1997, The American journal of pathology.
[71] C. Hsieh,et al. Prevention of Hypoxia-Induced Pulmonary Hypertension by Enhancement of Endogenous Heme Oxygenase-1 in the Rat. • 238 , 1997, Pediatric Research.
[72] B. Thompson,et al. The role of Na+/H+ exchange and growth factors in pulmonary artery smooth muscle cell proliferation. , 1996, American journal of respiratory cell and molecular biology.
[73] R. McIntyre,et al. Mechanistic imbalance of pulmonary vasomotor control in progressive lung injury. , 1996, Surgery.
[74] B. Thompson,et al. Na+/H+ exchange in pulmonary artery smooth muscle from spontaneously hypertensive and Wistar-Kyoto rats. , 1995, The American journal of physiology.
[75] G. Pietra. Histopathology of primary pulmonary hypertension. , 1994, Chest.
[76] S. Rich,et al. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.
[77] B. Thompson,et al. Contribution of Na+/H+ exchange to pH regulation in pulmonary artery smooth muscle cells. , 1991, American journal of respiratory cell and molecular biology.
[78] P. Braquet,et al. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. , 1991, The Journal of clinical investigation.
[79] L. Ignarro. Nitric oxide. A novel signal transduction mechanism for transcellular communication. , 1990, Hypertension.
[80] B. Groves,et al. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. , 1989, Circulation.
[81] R. Khalil,et al. Sustained contraction of vascular smooth muscle: calcium influx or C-kinase activation? , 1988, The Journal of pharmacology and experimental therapeutics.
[82] M. Gillespie,et al. Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats. , 1986, The American journal of physiology.